Concepts (254)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sheep | 27 | 2019 | 221 | 2.460 |
Why?
|
| Mesenchymal Stem Cells | 16 | 2018 | 161 | 2.180 |
Why?
|
| Retroviridae | 9 | 2012 | 25 | 1.660 |
Why?
|
| Transduction, Genetic | 7 | 2013 | 42 | 1.470 |
Why?
|
| Cosmic Radiation | 2 | 2018 | 13 | 1.310 |
Why?
|
| Hematopoietic Stem Cells | 10 | 2018 | 95 | 1.270 |
Why?
|
| Cell Differentiation | 16 | 2018 | 436 | 1.160 |
Why?
|
| Bone Marrow Cells | 6 | 2018 | 114 | 1.150 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 10 | 2013 | 75 | 1.120 |
Why?
|
| Models, Animal | 9 | 2014 | 160 | 1.060 |
Why?
|
| Genetic Vectors | 11 | 2019 | 118 | 1.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 8 | 2016 | 83 | 1.040 |
Why?
|
| Fetus | 9 | 2016 | 78 | 0.930 |
Why?
|
| Hemophilia A | 3 | 2013 | 17 | 0.900 |
Why?
|
| Regenerative Medicine | 2 | 2015 | 187 | 0.830 |
Why?
|
| Hematopoiesis | 4 | 2018 | 34 | 0.810 |
Why?
|
| Gestational Age | 6 | 2014 | 96 | 0.810 |
Why?
|
| Antigens, CD34 | 10 | 2015 | 54 | 0.730 |
Why?
|
| Animals | 32 | 2019 | 7297 | 0.710 |
Why?
|
| Dendritic Cells | 2 | 2018 | 61 | 0.710 |
Why?
|
| Fetal Therapies | 1 | 2019 | 2 | 0.690 |
Why?
|
| Weightlessness | 1 | 2018 | 5 | 0.660 |
Why?
|
| Transgenes | 3 | 2008 | 45 | 0.640 |
Why?
|
| Immunity, Innate | 1 | 2018 | 64 | 0.640 |
Why?
|
| Factor VIII | 3 | 2013 | 19 | 0.640 |
Why?
|
| Gene Transfer Techniques | 3 | 2019 | 69 | 0.630 |
Why?
|
| Stem Cells | 6 | 2018 | 292 | 0.580 |
Why?
|
| Hematologic Diseases | 2 | 2015 | 23 | 0.550 |
Why?
|
| Immune Tolerance | 3 | 2015 | 67 | 0.540 |
Why?
|
| Stem Cell Transplantation | 5 | 2010 | 203 | 0.520 |
Why?
|
| Immunomodulation | 2 | 2013 | 30 | 0.500 |
Why?
|
| Receptors, Virus | 2 | 2012 | 15 | 0.490 |
Why?
|
| Immunity, Humoral | 1 | 2013 | 12 | 0.480 |
Why?
|
| Dependovirus | 1 | 2013 | 17 | 0.470 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2013 | 23 | 0.460 |
Why?
|
| Antibodies, Viral | 1 | 2013 | 55 | 0.460 |
Why?
|
| Pregnancy | 10 | 2019 | 815 | 0.460 |
Why?
|
| Liver Regeneration | 2 | 2010 | 23 | 0.450 |
Why?
|
| Humans | 36 | 2019 | 29093 | 0.430 |
Why?
|
| Fetal Blood | 4 | 2018 | 35 | 0.430 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2019 | 11 | 0.420 |
Why?
|
| Uterus | 2 | 2019 | 73 | 0.410 |
Why?
|
| Graft Survival | 6 | 2016 | 228 | 0.410 |
Why?
|
| Liver Diseases | 1 | 2010 | 61 | 0.360 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 92 | 0.360 |
Why?
|
| Germ Cells | 1 | 2009 | 11 | 0.350 |
Why?
|
| Antigen Presentation | 1 | 2008 | 9 | 0.330 |
Why?
|
| DNA Damage | 2 | 2018 | 88 | 0.310 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 980 | 0.310 |
Why?
|
| Cell Proliferation | 6 | 2018 | 573 | 0.300 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 196 | 0.300 |
Why?
|
| Mice | 6 | 2019 | 2368 | 0.290 |
Why?
|
| Transplantation, Heterologous | 10 | 2015 | 121 | 0.280 |
Why?
|
| Cell Movement | 3 | 2012 | 161 | 0.280 |
Why?
|
| Proviruses | 1 | 2005 | 3 | 0.280 |
Why?
|
| Spermatozoa | 1 | 2005 | 27 | 0.270 |
Why?
|
| Endothelial Cells | 3 | 2016 | 179 | 0.250 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2005 | 68 | 0.250 |
Why?
|
| Gene Expression Profiling | 2 | 2005 | 320 | 0.250 |
Why?
|
| Neoplasms | 1 | 2010 | 610 | 0.240 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 152 | 0.240 |
Why?
|
| Fetal Diseases | 1 | 2004 | 15 | 0.240 |
Why?
|
| Female | 13 | 2019 | 18164 | 0.240 |
Why?
|
| Intestines | 2 | 2013 | 54 | 0.220 |
Why?
|
| Cytomegalovirus | 2 | 2013 | 20 | 0.220 |
Why?
|
| Viral Proteins | 2 | 2013 | 42 | 0.220 |
Why?
|
| Bone Marrow Transplantation | 2 | 2016 | 65 | 0.210 |
Why?
|
| Recombinant Proteins | 2 | 2012 | 248 | 0.200 |
Why?
|
| Flow Cytometry | 4 | 2010 | 171 | 0.180 |
Why?
|
| Islets of Langerhans | 2 | 2010 | 74 | 0.180 |
Why?
|
| Liver | 4 | 2012 | 464 | 0.170 |
Why?
|
| Cell Lineage | 5 | 2013 | 67 | 0.170 |
Why?
|
| Consensus | 1 | 2019 | 68 | 0.170 |
Why?
|
| Bleomycin | 1 | 2018 | 10 | 0.170 |
Why?
|
| Astronauts | 1 | 2018 | 7 | 0.170 |
Why?
|
| Prenatal Care | 1 | 2019 | 46 | 0.170 |
Why?
|
| Solar Energy | 1 | 2018 | 4 | 0.160 |
Why?
|
| Bystander Effect | 1 | 2018 | 6 | 0.160 |
Why?
|
| Protons | 1 | 2018 | 23 | 0.160 |
Why?
|
| Histones | 1 | 2018 | 49 | 0.160 |
Why?
|
| DNA Repair | 1 | 2018 | 50 | 0.160 |
Why?
|
| Hepatocytes | 4 | 2007 | 74 | 0.160 |
Why?
|
| Iron | 1 | 2018 | 113 | 0.150 |
Why?
|
| Organ Specificity | 3 | 2006 | 77 | 0.150 |
Why?
|
| Sheep, Domestic | 2 | 2016 | 18 | 0.150 |
Why?
|
| Stem Cell Niche | 2 | 2014 | 25 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2012 | 248 | 0.150 |
Why?
|
| Blood Transfusion, Intrauterine | 1 | 2016 | 4 | 0.140 |
Why?
|
| Cells, Cultured | 5 | 2018 | 799 | 0.140 |
Why?
|
| Transplantation Chimera | 5 | 2007 | 21 | 0.140 |
Why?
|
| Models, Biological | 2 | 2008 | 373 | 0.140 |
Why?
|
| RNA-Binding Proteins | 2 | 2013 | 68 | 0.140 |
Why?
|
| Electromagnetic Fields | 1 | 2015 | 26 | 0.130 |
Why?
|
| Autoimmune Diseases | 1 | 2015 | 50 | 0.130 |
Why?
|
| Tissue Distribution | 2 | 2013 | 55 | 0.130 |
Why?
|
| Injections, Intraperitoneal | 2 | 2011 | 41 | 0.120 |
Why?
|
| Amniotic Fluid | 1 | 2015 | 84 | 0.120 |
Why?
|
| Phenotype | 3 | 2011 | 629 | 0.120 |
Why?
|
| Neutralization Tests | 1 | 2013 | 12 | 0.120 |
Why?
|
| Capsid | 1 | 2013 | 9 | 0.120 |
Why?
|
| Immune Evasion | 1 | 2013 | 2 | 0.120 |
Why?
|
| Epitopes | 1 | 2013 | 21 | 0.120 |
Why?
|
| Luciferases | 1 | 2013 | 27 | 0.120 |
Why?
|
| Membrane Proteins | 2 | 2013 | 256 | 0.120 |
Why?
|
| Crystallography, X-Ray | 1 | 2013 | 77 | 0.120 |
Why?
|
| Transplantation, Homologous | 2 | 2016 | 113 | 0.120 |
Why?
|
| Transplantation, Autologous | 2 | 2015 | 78 | 0.120 |
Why?
|
| Immediate-Early Proteins | 1 | 2013 | 9 | 0.120 |
Why?
|
| Complement System Proteins | 1 | 2013 | 9 | 0.110 |
Why?
|
| Viral Envelope Proteins | 1 | 2013 | 15 | 0.110 |
Why?
|
| Receptor, EphB2 | 1 | 2013 | 6 | 0.110 |
Why?
|
| Glycoproteins | 1 | 2013 | 34 | 0.110 |
Why?
|
| Cell Culture Techniques | 2 | 2018 | 165 | 0.110 |
Why?
|
| Intestinal Mucosa | 1 | 2013 | 64 | 0.110 |
Why?
|
| Cell Line | 3 | 2012 | 449 | 0.110 |
Why?
|
| Genetic Engineering | 1 | 2012 | 19 | 0.110 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2012 | 35 | 0.110 |
Why?
|
| Killer Cells, Natural | 2 | 2012 | 24 | 0.110 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2012 | 82 | 0.110 |
Why?
|
| Hemarthrosis | 1 | 2011 | 3 | 0.100 |
Why?
|
| Sus scrofa | 1 | 2011 | 44 | 0.100 |
Why?
|
| Isoantibodies | 1 | 2011 | 10 | 0.100 |
Why?
|
| Remission Induction | 1 | 2011 | 78 | 0.100 |
Why?
|
| Antibody Specificity | 2 | 2008 | 14 | 0.100 |
Why?
|
| Adult | 2 | 2019 | 8420 | 0.100 |
Why?
|
| Blotting, Western | 1 | 2012 | 281 | 0.100 |
Why?
|
| Insulin | 2 | 2010 | 346 | 0.100 |
Why?
|
| Hemorrhage | 1 | 2011 | 90 | 0.100 |
Why?
|
| Immunosuppression | 1 | 2010 | 80 | 0.090 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 30 | 0.090 |
Why?
|
| Sertoli Cells | 1 | 2009 | 5 | 0.090 |
Why?
|
| Docosahexaenoic Acids | 1 | 2009 | 20 | 0.090 |
Why?
|
| DNA | 2 | 2010 | 204 | 0.080 |
Why?
|
| Thymus Gland | 1 | 2008 | 15 | 0.080 |
Why?
|
| Autoantigens | 1 | 2008 | 16 | 0.080 |
Why?
|
| Culture Media, Serum-Free | 1 | 2008 | 15 | 0.080 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2008 | 8 | 0.080 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2008 | 33 | 0.080 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2007 | 6 | 0.080 |
Why?
|
| Stromal Cells | 1 | 2008 | 70 | 0.080 |
Why?
|
| Time Factors | 4 | 2009 | 2001 | 0.080 |
Why?
|
| Male | 3 | 2011 | 17807 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2008 | 138 | 0.080 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2009 | 173 | 0.070 |
Why?
|
| Apoptosis | 1 | 2009 | 337 | 0.070 |
Why?
|
| RNA, Messenger | 4 | 2013 | 514 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 2 | 2004 | 81 | 0.070 |
Why?
|
| Age Factors | 1 | 2009 | 1108 | 0.070 |
Why?
|
| Amino Acid Transport System ASC | 1 | 2005 | 1 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 172 | 0.070 |
Why?
|
| Testis | 1 | 2005 | 60 | 0.070 |
Why?
|
| Transfection | 1 | 2005 | 192 | 0.070 |
Why?
|
| Membrane Transport Proteins | 1 | 2005 | 34 | 0.060 |
Why?
|
| Infusions, Parenteral | 1 | 2005 | 64 | 0.060 |
Why?
|
| Tissue Engineering | 1 | 2010 | 608 | 0.060 |
Why?
|
| Bone Marrow | 3 | 2014 | 60 | 0.060 |
Why?
|
| Purkinje Fibers | 1 | 2004 | 3 | 0.060 |
Why?
|
| Fetal Heart | 1 | 2004 | 5 | 0.060 |
Why?
|
| Lung | 1 | 2005 | 233 | 0.060 |
Why?
|
| Mesoderm | 1 | 2002 | 14 | 0.060 |
Why?
|
| Gene Expression | 2 | 2016 | 332 | 0.060 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2002 | 4 | 0.060 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2002 | 5 | 0.050 |
Why?
|
| beta-Galactosidase | 1 | 2002 | 16 | 0.050 |
Why?
|
| Risk Factors | 1 | 2009 | 3531 | 0.050 |
Why?
|
| Immunophenotyping | 2 | 2009 | 49 | 0.040 |
Why?
|
| Kidney | 1 | 2002 | 485 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2010 | 519 | 0.040 |
Why?
|
| Ferrets | 1 | 2018 | 19 | 0.040 |
Why?
|
| Cell Separation | 2 | 2009 | 86 | 0.040 |
Why?
|
| Brain | 1 | 2005 | 930 | 0.040 |
Why?
|
| Membrane Glycoproteins | 2 | 2009 | 97 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2016 | 22 | 0.040 |
Why?
|
| Chemokine CXCL12 | 1 | 2016 | 25 | 0.040 |
Why?
|
| Antigens, CD | 2 | 2008 | 100 | 0.030 |
Why?
|
| Chondrogenesis | 1 | 2015 | 18 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2015 | 25 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2015 | 71 | 0.030 |
Why?
|
| Osteogenesis | 1 | 2015 | 75 | 0.030 |
Why?
|
| Fetal Development | 1 | 2014 | 25 | 0.030 |
Why?
|
| Osteoblasts | 1 | 2014 | 46 | 0.030 |
Why?
|
| Secretory Vesicles | 1 | 2013 | 4 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 62 | 0.030 |
Why?
|
| Intestine, Small | 1 | 2013 | 34 | 0.030 |
Why?
|
| von Willebrand Factor | 1 | 2012 | 17 | 0.030 |
Why?
|
| Thrombin | 1 | 2012 | 15 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2012 | 21 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2012 | 13 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 71 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2012 | 36 | 0.030 |
Why?
|
| Cricetinae | 1 | 2012 | 58 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 95 | 0.030 |
Why?
|
| Kanamycin Kinase | 1 | 2012 | 3 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2013 | 89 | 0.030 |
Why?
|
| Protein Binding | 1 | 2012 | 199 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2012 | 35 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 118 | 0.030 |
Why?
|
| HLA Antigens | 1 | 2012 | 35 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2012 | 143 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 711 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 87 | 0.020 |
Why?
|
| Reference Standards | 1 | 2010 | 30 | 0.020 |
Why?
|
| Base Sequence | 1 | 2010 | 240 | 0.020 |
Why?
|
| Organic Chemicals | 1 | 2009 | 7 | 0.020 |
Why?
|
| Mitosis | 1 | 2009 | 22 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2009 | 7 | 0.020 |
Why?
|
| Annexin A5 | 1 | 2009 | 8 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2009 | 45 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2009 | 14 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2009 | 30 | 0.020 |
Why?
|
| Kinetics | 1 | 2009 | 205 | 0.020 |
Why?
|
| Cell Fusion | 1 | 2008 | 3 | 0.020 |
Why?
|
| Cell-Derived Microparticles | 1 | 2008 | 5 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 3099 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2009 | 163 | 0.020 |
Why?
|
| Antigens, CD7 | 1 | 2008 | 4 | 0.020 |
Why?
|
| Cell Survival | 1 | 2009 | 272 | 0.020 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2008 | 4 | 0.020 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2008 | 6 | 0.020 |
Why?
|
| Stem Cell Factor | 1 | 2008 | 13 | 0.020 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2008 | 17 | 0.020 |
Why?
|
| Clone Cells | 1 | 2007 | 36 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2008 | 74 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2007 | 24 | 0.020 |
Why?
|
| Injections | 1 | 2007 | 61 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2010 | 466 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 641 | 0.020 |
Why?
|
| Mitochondria | 1 | 2008 | 174 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 680 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2008 | 598 | 0.020 |
Why?
|
| Lac Operon | 1 | 2005 | 5 | 0.020 |
Why?
|
| K562 Cells | 1 | 2005 | 4 | 0.020 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2005 | 6 | 0.020 |
Why?
|
| Virus Integration | 1 | 2005 | 3 | 0.020 |
Why?
|
| Hela Cells | 1 | 2005 | 78 | 0.020 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 2004 | 4 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2004 | 35 | 0.020 |
Why?
|
| Transplantation | 1 | 2004 | 12 | 0.020 |
Why?
|
| Cell Count | 1 | 2004 | 50 | 0.020 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2004 | 5 | 0.020 |
Why?
|
| Fetal Tissue Transplantation | 1 | 2004 | 5 | 0.020 |
Why?
|
| Brain Tissue Transplantation | 1 | 2004 | 3 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2004 | 28 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2004 | 87 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 141 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2004 | 167 | 0.010 |
Why?
|
| X Chromosome | 1 | 2002 | 24 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2002 | 34 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2002 | 69 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2002 | 114 | 0.010 |
Why?
|
| Mutation | 1 | 2002 | 466 | 0.010 |
Why?
|
| Infant | 1 | 2002 | 969 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2002 | 1167 | 0.010 |
Why?
|
| Child | 1 | 2002 | 2219 | 0.010 |
Why?
|